Amy Timpson is a Clinical Account Manager at Promega Corporation, where responsibilities include enhancing genetic testing workflows in diagnostic virology, rare and inherited diseases, and oncology laboratories, achieving double-digit growth in 2019. Previously, Amy served as a Product Manager - Genomics, focusing on business development in the UK for academic, government, clinical, pharmaceutical, and biotechnology sectors. Prior experience includes working as a Key Account Representative at Merck Group, where Amy provided scientific advisory services and built relationships with Key Opinion Leaders at prominent institutions. Academic qualifications include a PhD in Cardiovascular Endocrinology and a Bachelor's degree in Veterinary Sciences, both from the University of London.